Sandoz Group AG (SDZNY)
OTCMKTS
· Delayed Price · Currency is USD
40.95
+0.84 (2.11%)
Apr 24, 2025, 12:58 PM EDT
Sandoz Group AG Revenue
In the year 2024, Sandoz Group AG had annual revenue of $10.38B with 4.06% growth. Sandoz Group AG had revenue of $5.32B in the half year ending December 31, 2024, with 14.92% growth.
Revenue
10.38B
Revenue Growth
+4.06%
P/S Ratio
1.67
Revenue / Employee
470.95K
Employees
22,049
Market Cap
17.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Sandoz Group AG News
- 9 days ago - Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG - GlobeNewsWire
- 10 days ago - Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug - Benzinga
- 10 days ago - [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US - GlobeNewsWire
- 10 days ago - Amgen faces antitrust lawsuit from Sandoz over Enbrel patents - Seeking Alpha
- 10 days ago - Sandoz files antitrust litigation against Amgen regarding patient access to etanercept ... - GuruFocus
- 10 days ago - Switzerland's Sandoz files antitrust lawsuit against Amgen in US - Reuters
- 10 days ago - Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US - GlobeNewsWire
- 18 days ago - Novartis After Sandoz: The Business Without Generics - Seeking Alpha